The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

Why does NZ suck at building brands
Markets

Eden Bradfield: Why does NZ suck at building brands

Let the French have Fonterra brands, Eden Bradfield writes.

Eden Bradfield 06 Sep 2025
NZ sharemarket ends week up 2.2%
Markets Market Close

NZ sharemarket ends week up 2.2%

The S&P/NZX 50 Index closed at 13,223.53, up 90.32 points or 0.69%.

Graham Skellern 05 Sep 2025
Fletcher Building slashes maximum CEO pay
Markets

Fletcher Building slashes maximum CEO pay

 Total maximum remuneration is now $2m lower at $5.8m.

Rebecca Howard 05 Sep 2025
Westpac NZ eyes monetary policy reform for change-laden RBNZ
Economy

Westpac NZ eyes monetary policy reform for change-laden RBNZ

Westpac NZ puts monetary policy voting in the spotlight.

Staff reporters 05 Sep 2025